Study protocol for a Prospective, Randomized controlled trial of stEnt graft and Drug-coated bAlloon Treatment for cephalic arch stenOsis in dysfunctional arteRio-venous fistulas (PREDATOR).

Cephalic arch stenosis angioplasty arteriovenous fistula paclitaxel stent graft

Journal

The journal of vascular access
ISSN: 1724-6032
Titre abrégé: J Vasc Access
Pays: United States
ID NLM: 100940729

Informations de publication

Date de publication:
03 Nov 2022
Historique:
pubmed: 5 11 2022
medline: 5 11 2022
entrez: 4 11 2022
Statut: aheadofprint

Résumé

Treatment of cephalic arch stenosis (CAS) is associated with high risk of failure and complications. Although stent-graft (SG) placement has improved patency rates, stent edge restenosis has been raised as a potential limiting factor for SG usage in CAS. This study aims to evaluate the safety and efficacy of combining stent graft placement with paclitaxel-coated balloon (PCB) angioplasty versus PCB alone in the treatment of CAS. This is an investigator-initiated, prospective, international, multicenter, open-label, randomized control clinical trial that plans to recruit 80 patients, who require fistuloplasty from dysfunctional arteriovenous fistula (AVF) from CAS. Eligible participants are randomly assigned to receive treatment with SG and PCB or PCB alone in a 1:1 ratio post-angioplasty ( This study will evaluate the clinical efficacy and safety of combination SG and PCB implantation compared to PCB alone in the treatment of CAS for hemodialysis patients.

Sections du résumé

BACKGROUND UNASSIGNED
Treatment of cephalic arch stenosis (CAS) is associated with high risk of failure and complications. Although stent-graft (SG) placement has improved patency rates, stent edge restenosis has been raised as a potential limiting factor for SG usage in CAS. This study aims to evaluate the safety and efficacy of combining stent graft placement with paclitaxel-coated balloon (PCB) angioplasty versus PCB alone in the treatment of CAS.
METHODS UNASSIGNED
This is an investigator-initiated, prospective, international, multicenter, open-label, randomized control clinical trial that plans to recruit 80 patients, who require fistuloplasty from dysfunctional arteriovenous fistula (AVF) from CAS. Eligible participants are randomly assigned to receive treatment with SG and PCB or PCB alone in a 1:1 ratio post-angioplasty (
DISCUSSION UNASSIGNED
This study will evaluate the clinical efficacy and safety of combination SG and PCB implantation compared to PCB alone in the treatment of CAS for hemodialysis patients.

Identifiants

pubmed: 36330556
doi: 10.1177/11297298221130897
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

11297298221130897

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Chye Chung Gan (CC)

Department of Renal Medicine, Singapore General Hospital, Singapore.
Department of Medicine, Faculty of Medicine, University of Malaya, Malaysia.

Ru Yu Tan (RY)

Department of Renal Medicine, Singapore General Hospital, Singapore.
Duke NUS Graduate Medical School, Singapore.

Christopher L Delaney (CL)

Department of Vascular and Endovascular Surgery, Flinders Medical Centre, South Australia, Australia.

Phillip J Puckridge (PJ)

Department of Vascular and Endovascular Surgery, Flinders Medical Centre, South Australia, Australia.

Suh Chien Pang (SC)

Department of Renal Medicine, Singapore General Hospital, Singapore.
Duke NUS Graduate Medical School, Singapore.

Alvin Ren Kwang Tng (ARK)

Department of Renal Medicine, Singapore General Hospital, Singapore.
Duke NUS Graduate Medical School, Singapore.

Chee Wooi Tan (CW)

Department of Renal Medicine, Singapore General Hospital, Singapore.
Duke NUS Graduate Medical School, Singapore.

Chieh Suai Tan (CS)

Department of Renal Medicine, Singapore General Hospital, Singapore.
Duke NUS Graduate Medical School, Singapore.

Alfred Bingchao Tan (AB)

Duke NUS Graduate Medical School, Singapore.
Department of Vascular and Interventional Radiology, Singapore General Hospital, Singapore.

Kun Da Zhuang (KD)

Duke NUS Graduate Medical School, Singapore.
Department of Vascular and Interventional Radiology, Singapore General Hospital, Singapore.

Apoorva Gogna (A)

Duke NUS Graduate Medical School, Singapore.
Department of Vascular and Interventional Radiology, Singapore General Hospital, Singapore.

Kiang Hiong Tay (KH)

Duke NUS Graduate Medical School, Singapore.
Department of Vascular and Interventional Radiology, Singapore General Hospital, Singapore.

Sze Ling Chan (SL)

Health Services Research Centre, SingHealth Duke-NUS Academic Medical Centre, Singapore.

Charyl Jia Qi Yap (CJQ)

Duke NUS Graduate Medical School, Singapore.
Department of Vascular Surgery, Singapore General Hospital, Singapore.

Tze Tec Chong (TT)

Duke NUS Graduate Medical School, Singapore.
Department of Vascular Surgery, Singapore General Hospital, Singapore.

Tjun Yip Tang (TY)

Duke NUS Graduate Medical School, Singapore.
Department of Vascular and Endovascular Surgery, Flinders Medical Centre, South Australia, Australia.

Classifications MeSH